Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"26,428 (15,846, 39,560)","51.9% (37.3%, 63.1%)","73.3% (52.8%, 88.3%)","17.7% (8.8%, 35.4%)","49.5% (35.0%, 60.3%)","18.2 (13.0, 22.1)","25.6 (18.5, 30.9)","6.2 (3.1, 12.4)","17.3 (12.3, 21.1)",,,,,
"(p=None, None), q=(None, None), c=0.500)","22,358 (11,191, 36,582)","61.7% (43.4%, 77.1%)","42.0% (27.4%, 57.4%)","9.3% (5.5%, 15.5%)","59.0% (41.0%, 74.0%)","21.6 (15.2, 27.0)","14.7 (9.6, 20.1)","3.2 (1.9, 5.4)","20.6 (14.3, 25.9)","-16.2% (-33.9%, -3.2%)","18.9% (6.4%, 40.9%)","-42.6% (-61.7%, -18.8%)","-43.4% (-74.7%, -3.2%)","19.1% (6.6%, 40.7%)"
"(p=None, None), q=(None, None), c=0.750)","22,462 (11,504, 35,865)","61.9% (43.4%, 77.7%)","41.1% (26.7%, 57.1%)","8.9% (5.3%, 15.2%)","59.4% (41.0%, 75.1%)","21.7 (15.2, 27.2)","14.4 (9.4, 20.0)","3.1 (1.8, 5.3)","20.8 (14.3, 26.3)","-15.8% (-34.5%, -3.2%)","19.4% (6.6%, 41.4%)","-43.7% (-62.8%, -19.0%)","-45.4% (-75.7%, -6.3%)","20.1% (6.8%, 42.8%)"
"(p=None, None), q=(None, None), c=1.000)","22,541 (11,759, 36,282)","62.2% (44.0%, 78.6%)","40.7% (26.4%, 56.6%)","8.6% (5.1%, 14.4%)","59.8% (41.7%, 76.1%)","21.8 (15.4, 27.5)","14.2 (9.2, 19.8)","3.0 (1.8, 5.0)","20.9 (14.6, 26.7)","-15.4% (-33.4%, -3.4%)","20.1% (7.3%, 37.9%)","-44.3% (-63.4%, -20.8%)","-47.2% (-76.2%, -9.4%)","20.9% (7.7%, 39.7%)"
